Search Results - sailaja+gangadhara

2 Results Sort By:
MVA and DNA Based SARS-CoV-2 Vaccines
Application Modified Vaccinia virus Ankara (MVA)- and deoxyribonucleic acid (DNA)-based vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Key Benefits Safety profile is known. Demonstrated antiviral activity against related Coronaviruses. Single dose of vaccination was shown to be effective against related Coronaviruses...
Published: 2/13/2025   |   Inventor(s): Rama Rao Amara, Sailaja Gangadhara
Keywords(s): Biologics, COVID19, DNA and RNA Vaccines, Immunology and Inflammation Treatments, Microbiology and Infectious Disease Treatments
Category(s): TechPub Algolia > Vaccines
HIV-1 Clade C Protein Immunogen as HIV-1 Vaccine
Application Novel stabilized HIV-1 Clade C gp140 trimeric immunogen useful as a vaccine. Key Benefits Vaccine for HIV-1 infections. Induces both neutralizing and V1V2 scaffold directed antibody responses. V1V2 scaffold directed antibodies bind to multiple strains of HIV-1 from different clades including Clades B and C. Market Summary HIV-1...
Published: 2/13/2025   |   Inventor(s): Rama Rao Amara, Sailaja Gangadhara, Tiffany Styles, Anusmita Sahoo
Keywords(s): Immunology and Inflammation Treatments, Microbiology and Infectious Disease Treatments, Therapeutic Vaccines
Category(s): TechPub Algolia > Vaccines